Nature Communications (Jan 2024)

Innate immune and proinflammatory signals activate the Hippo pathway via a Tak1-STRIPAK-Tao axis

  • Yinan Yang,
  • Huijing Zhou,
  • Xiawei Huang,
  • Chengfang Wu,
  • Kewei Zheng,
  • Jingrong Deng,
  • Yonggang Zheng,
  • Jiahui Wang,
  • Xiaofeng Chi,
  • Xianjue Ma,
  • Huimin Pan,
  • Rui Shen,
  • Duojia Pan,
  • Bo Liu

DOI
https://doi.org/10.1038/s41467-023-44542-y
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 17

Abstract

Read online

Abstract The Hippo pathway controls developmental, homeostatic and regenerative tissue growth, and is frequently dysregulated in various diseases. Although this pathway can be activated by innate immune/inflammatory stimuli, the underlying mechanism is not fully understood. Here, we identify a conserved signaling cascade that leads to Hippo pathway activation by innate immune/inflammatory signals. We show that Tak1, a key kinase in innate immune/inflammatory signaling, activates the Hippo pathway by inducing the lysosomal degradation of Cka, an essential subunit of the STRIPAK PP2A complex that suppresses Hippo signaling. Suppression of STRIPAK results in the activation of Hippo pathway through Tao-Hpo signaling. We further show that Tak1-mediated Hippo signaling is involved in processes ranging from cell death to phagocytosis and innate immune memory. Our findings thus reveal a molecular connection between innate immune/inflammatory signaling and the evolutionally conserved Hippo pathway, thus contributing to our understanding of infectious, inflammatory and malignant diseases.